Naturalendo Tech Co., Ltd. (KOSDAQ: A168330)
Health Care · Biotechnology · KR
₩2,125.00
-11.09% today · -15.0% 1Y
Naturalendo Tech Co., Ltd. (KOSDAQ: A168330) operates in the Biotechnology industry within the Health Care sector. The company is valued at $50.32M.
Over the last twelve months the share price has lost 15.0%, trading between 1.67K and 4.10K.
Tweenvest scores Naturalendo Tech Co., Ltd. across four factors: quality 73/100, value 72/100. Its strongest factor is quality.
A168330 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $50.32M
- Revenue (TTM)
- $14.72M
- P/E
- —
- EPS
- -51.71
- Dividend yield
- —
- Beta (5Y)
- 0.99
- 52-week high
- ₩4,100.00
- 52-week low
- ₩1,668.00
- Avg volume (3M)
- —
- Shares outstanding
- 31.57M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Uni-Bio Science Group LimitedSEHK: 690 | $50.98M | HK$0.07 | -4.29% |
| Rein Therapeutics Inc.NasdaqCM: RNTX | $50.92M | $0.59 | -25.65% |
| Cellid, Co., Ltd.KOSDAQ: A299660 | $50.90M | ₩2,300.00 | -8.18% |
| FluoGuide A/SOM: FLUO | $50.52M | Skr30.60 | -3.47% |
| Kidswell Bio CorporationTSE: 4584 | $50.31M | ¥157.00 | -1.88% |
| Elicio Therapeutics, Inc.NasdaqCM: ELTX | $49.94M | $1.90 | -2.06% |
| Arecor Therapeutics plcAIM: AREC | $49.86M | £0.83 | +13.79% |
| Alterity Therapeutics LimitedASX: ATH | $49.42M | AU$0.31 | -12.68% |
Figures last refreshed Oct 18, 2026.